|
|
| Product Name: | ML-184 | | Synonyms: | ML-184;3-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]carbonyl]-N,N-dimethyl-4-(1-pyrrolidinyl)benzenesulfonamide;3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-pyrrolidin-1-ylbenzenesulfonamide;3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-(pyrrolidin-1-yl)benzene-1-sulfonamide;Benzenesulfonamide, 3-[[4-(2,3-dimethylphenyl)-1-piperazinyl]carbonyl]-N,N-dimethyl-4-(1-pyrrolidinyl)-;CID2440433;ML184,ML-184,inhibit,CID 2440433,ML 184,G protein-coupled receptor 55,CID-2440433,Inhibitor,GPR55 | | CAS: | 794572-10-4 | | MF: | C25H34N4O3S | | MW: | 470.63 | | EINECS: | | | Product Categories: | | | Mol File: | 794572-10-4.mol |  |
| | ML-184 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 30 mg/ml; DMF:PBS (pH 7.2) (1:4): 0.2 mg/ml; DMSO: 20 mg/ml; Ethanol: 1 mg/ml | | form | A crystalline solid |
| | ML-184 Usage And Synthesis |
| Description | CID2440433, also known as ML-184, is a potent synthetic agonist of GPR55 (EC50 = 0.26 μM). GPR55 is a G protein-coupled receptor that is weakly activated by some cannabinoids (CBs) at nM concentrations but displays a 5- to 10-fold greater stimulation in response to 1 μM lysophosphatidylinositol (LPI). | | Definition | ChEBI: 3-[[4-(2,3-dimethylphenyl)-1-piperazinyl]-oxomethyl]-N,N-dimethyl-4-(1-pyrrolidinyl)benzenesulfonamide is a member of piperazines. | | storage | Store at +4°C |
| | ML-184 Preparation Products And Raw materials |
|